Pivotal bioVenture Partners (U.S.), an affiliate of Pivotal Life Sciences We back the brightest minds in life sciences. Our seasoned investment team brings over 50 years combined biotech venture capital and company building experience from top tier funds including Novo Ventures, TPG Biotech, Bay City Capital, NEA, and SV Life Sciences. We strive to leverage this extended network and expertise in evaluating new investment opportunities, building value in our portfolio, and in contributing management talent and referrals to our companies. We invest at all stages in a company’s evolution, from company creation through mid and late stage clinical development. We are capable of leading or co-leading transactions, and employ a rigorous investment review process that distinguishes us and helps us with syndicate building and positioning companies well for a future public offering or M&A event.
22
Total Investments
16
Portfolio Companies
-
Exits
3
Industries
General Information
Industries
Finance, Financial Services +1
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About Nan Fung Life Sciences
Recent Investments (22)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Series A | •••••• | Dec 2021 | |
| Growth Equity Vc | •••••• | Dec 2021 | |
| Series A | •••••• | Nov 2021 | |
| Series A | •••••• | Nov 2021 | |
| Series C | •••••• | May 2021 | |
|
|
Series B | •••••• | Mar 2021 |
|
|
Series C | •••••• | Jan 2021 |
|
|
Series E | •••••• | Jul 2020 |
|
|
Series A | •••••• | Jul 2020 |
|
|
Series A | •••••• | Feb 2020 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.